SC2disease: a manually curated database of single-cell transcriptome for human diseases

Tianyi Zhao, Shuxuan Lyu, Guilin Lu, Liran Juan, Xi Zeng, Zhongyu Wei, Jianye Hao, Jiajie PengNucleic Acids Res 2021 · DOI · OpenReview

TL;DR

Researchers have developed SC2disease, a comprehensive, manually curated database that aggregates single-cell RNA sequencing (scRNA-seq) data for human diseases. This resource addresses the lack of centralized, cell-type-specific gene expression information across various diseases, enabling deeper insights into disease mechanisms and potential therapeutic targets.

What Problem Does This Paper Address?

The advent of single-cell RNA sequencing (scRNA-seq) has revolutionized our ability to study cellular heterogeneity, particularly in the context of diseases. By profiling gene expression at the individual cell level, scRNA-seq allows researchers to identify distinct cell types and their unique transcriptomic profiles within complex tissues. This capability is crucial for understanding how diseases manifest and progress at a cellular level, offering new avenues for diagnosis and treatment. However, despite the growing volume of scRNA-seq data related to human diseases, there has been a significant gap in centralized, systematically organized databases that specifically focus on cell-type-specific gene expression across a broad range of conditions. Existing databases often focus on general cell markers, specific developmental pathways, or only a limited set of diseases (like cancer). This lack of a comprehensive resource makes it challenging for researchers to compare gene expression patterns across different cell types, tissues, and diseases, hindering the discovery of disease-specific cellular mechanisms and biomarkers.

Methods

The SC2disease database was constructed through a two-pronged approach:

  • Manual Curation: The researchers meticulously reviewed literature published before March 2020 that utilized scRNA-seq for human disease research. From these studies, they manually extracted and compiled information on differentially expressed genes (DEGs) in various cell types and disease tissues.
  • Unified Reanalysis Pipeline: To ensure comparability across studies that may have used different analytical pipelines, the raw gene expression matrices from selected studies were reanalyzed using a standardized pipeline. This pipeline involved:
  • Converting gene expression values to Transcripts Per Million (TPM).
  • Applying the Seurat R package for quality control, normalization, and identification of marker genes. Genes expressed in fewer than three cells, cells with fewer than 200 genes expressed, and cells with >5% mitochondrial RNA were excluded.

Datasets

The SC2disease database is built upon scRNA-seq studies of human diseases. The current version of the database includes data from 25 diseases, spanning 29 tissues and encompassing 341 distinct cell types. A total of 946,481 entries are documented. The database also integrates data from the GWAS Catalog to compare cell-type-specific genes with genes identified through genome-wide association studies.

Key Insights and Ideas

  • Bridging the Gap: SC2disease is the first manually curated resource specifically dedicated to cell-type-specific gene expression in human diseases, filling a critical void in the bioinformatics landscape.
  • Enhanced Comparability: The implementation of a unified reanalysis pipeline is a key innovation, allowing for more robust comparisons of gene expression data across diverse studies and experimental conditions.
  • Integrating Multi-omics: By linking scRNA-seq findings with GWAS data, SC2disease facilitates the exploration of potential genetic underpinnings of disease susceptibility at a cell-type-specific level.
  • Facilitating Discovery: The database's comprehensive nature and user-friendly interface are designed to empower researchers to easily search, browse, and download data, accelerating the discovery of disease biomarkers and therapeutic targets.

Key Results

The SC2disease database currently documents:

  • 946,481 entries.
  • 341 cell types.
  • 29 tissues.
  • 25 human diseases.

Each entry provides detailed information, including disease name, experimental tissue, cell type, gene name, gene expression values (e.g., log2FC, mean), DEG comparison details, publication identifier (PMID), and sequencing platform. The database also offers a user-friendly interface with a tree browser and search engine for data exploration.

Limitations and Future Work

The authors acknowledge that the database is a continuously evolving resource. As scRNA-seq technology advances and more studies become available, SC2disease is expected to be enriched and expanded. Future work will likely focus on incorporating new datasets, refining analytical pipelines, and potentially expanding the integration with other omics data types to provide an even more holistic understanding of human disease pathogenesis. The current version is limited to data available prior to March 2020, and future updates will incorporate more recent findings.

Summary updated

Abstract

SC2disease (http://easybioai.com/sc2disease/) is a manually curated database that aims to provide a comprehensive and accurate resource of gene expression profiles in various cell types for different diseases. With the development of single-cell RNA sequencing (scRNA-seq) technologies, uncovering cellular heterogeneity of different tissues for different diseases has become feasible by profiling transcriptomes across cell types at the cellular level. In particular, comparing gene expression profiles between different cell types and identifying cell-type-specific genes in various diseases offers new possibilities to address biological and medical questions. However, systematic, hierarchical and vast databases of gene expression profiles in human diseases at the cellular level are lacking. Thus, we reviewed the literature prior to March 2020 for studies which used scRNA-seq to study diseases with human samples, and developed the SC2disease database to summarize all the data by different diseases, tissues and cell types. SC2disease documents 946 481 entries, corresponding to 341 cell types, 29 tissues and 25 diseases. Each entry in the SC2disease database contains comparisons of differentially expressed genes between different cell types, tissues and disease-related health status. Furthermore, we reanalyzed gene expression matrix by unified pipeline to improve the comparability between different studies. For each disease, we also compare cell-type-specific genes with the corresponding genes of lead single nucleotide polymorphisms (SNPs) identified in genome-wide association studies (GWAS) to implicate cell type specificity of the traits.
BibTeX
@article{zhao2021sc,
  author = {Tianyi Zhao and Shuxuan Lyu and Guilin Lu and Liran Juan and Xi Zeng and Zhongyu Wei and Jianye Hao and Jiajie Peng},
  title = {{SC2disease: a manually curated database of single-cell transcriptome for human diseases}},
  journal = {Nucleic Acids Res.},
  year = {2021},
  doi = {10.1093/nar/gkaa838},
}
Figure